Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patientsBlood, 2015-05, Vol.125 (22), p.3501-3508 [Peer Reviewed Journal]2015 American Society of Hematology ;2015 by The American Society of Hematology. ;2015 by The American Society of Hematology 2015 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2014-12-615757 ;PMID: 25862561Full text available |
2 |
Material Type: Article
|
![]() |
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantationJournal of clinical oncology, 2014-10, Vol.32 (29), p.3249-3256, Article 3249 [Peer Reviewed Journal]2014 by American Society of Clinical Oncology. ;2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2013.53.8157 ;PMID: 25154831Full text available |
3 |
Material Type: Article
|
![]() |
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphomaBlood advances, 2020-11, Vol.4 (21), p.5414-5424 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 2473-9529 ;EISSN: 2473-9537 ;DOI: 10.1182/bloodadvances.2020003092 ;PMID: 33147337Full text available |
4 |
Material Type: Article
|
![]() |
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell TransplantationJournal of clinical oncology, 2013-04, Vol.31 (12), p.1530-1538 [Peer Reviewed Journal]2014 INIST-CNRS ;2013 by American Society of Clinical Oncology 2013 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.45.0247 ;PMID: 23478054Full text available |
5 |
Material Type: Article
|
![]() |
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433Haematologica (Roma), 2021-01, Vol.106 (1), p.46-55 [Peer Reviewed Journal]Copyright© 2021 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2019.237230 ;PMID: 32001530Full text available |
6 |
Material Type: Article
|
![]() |
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complicationNature communications, 2024-03, Vol.15 (1), p.2749-2749 [Peer Reviewed Journal]2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-47056-3 ;PMID: 38553461Full text available |
7 |
Material Type: Article
|
![]() |
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortalityBlood, 2014-07, Vol.124 (2), p.287-295 [Peer Reviewed Journal]2014 American Society of Hematology ;2014 by The American Society of Hematology. ;2014 by The American Society of Hematology 2014 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2014-01-550566 ;PMID: 24797298Full text available |
8 |
Material Type: Article
|
![]() |
Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative ConditioningJournal of clinical oncology, 2008-10, Vol.26 (30), p.4912-4920 [Peer Reviewed Journal]2008 INIST-CNRS ;Copyright © 2008, American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2007.15.4757 ;PMID: 18794548Full text available |
9 |
Material Type: Article
|
![]() |
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramBlood, 2009-04, Vol.113 (15), p.3604-3611 [Peer Reviewed Journal]2009 American Society of Hematology ;2009 INIST-CNRS ;2009 by The American Society of Hematology 2009 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2008-08-175323 ;PMID: 19190248Full text available |
10 |
Material Type: Article
|
![]() |
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid LeukemiaJournal of clinical oncology, 2010-06, Vol.28 (17), p.2859-2867 [Peer Reviewed Journal]2015 INIST-CNRS ;2010 by American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2009.27.1460 ;PMID: 20439626Full text available |
11 |
Material Type: Article
|
![]() |
Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T CellsCPT: pharmacometrics and systems pharmacology, 2019-05, Vol.8 (5), p.285-295 [Peer Reviewed Journal]2019 The Authors published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. ;2019. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2163-8306 ;EISSN: 2163-8306 ;DOI: 10.1002/psp4.12388 ;PMID: 30848084Full text available |
12 |
Material Type: Article
|
![]() |
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor ProgramBlood, 2013-01, Vol.121 (1), p.197-206 [Peer Reviewed Journal]2013 American Society of Hematology ;2014 INIST-CNRS ;2013 by The American Society of Hematology 2013 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-03-417667 ;PMID: 23109243Full text available |
13 |
Material Type: Article
|
![]() |
Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemiaHaematologica (Roma), 2017-07, Vol.102 (7), p.1291-1298 [Peer Reviewed Journal]Copyright© 2017 Ferrata Storti Foundation. ;Copyright© 2017 Ferrata Storti Foundation 2017 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2017.164459 ;PMID: 28341733Full text available |
14 |
Material Type: Article
|
![]() |
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myelomaHaematologica (Roma), 2019-02, Vol.104 (2), p.380-391 [Peer Reviewed Journal]Copyright © 2019 Ferrata Storti Foundation. ;Copyright © 2019 Ferrata Storti Foundation 2019 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2018.200253 ;PMID: 30262560Full text available |
15 |
Material Type: Article
|
![]() |
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell doseBlood, 2009-09, Vol.114 (13), p.2606-2616 [Peer Reviewed Journal]2009 American Society of Hematology ;2015 INIST-CNRS ;2009 by The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2009-03-208355 ;PMID: 19608747Full text available |
16 |
Material Type: Article
|
![]() |
Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantationBone marrow transplantation (Basingstoke), 2018-10, Vol.53 (10), p.1278-1287 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2018 ;ISSN: 0268-3369 ;EISSN: 1476-5365 ;DOI: 10.1038/s41409-018-0155-z ;PMID: 29581480Full text available |
17 |
Material Type: Article
|
![]() |
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modelingBlood advances, 2019-11, Vol.3 (21), p.3393-3405 [Peer Reviewed Journal]2019 American Society of Hematology ;ISSN: 2473-9529 ;EISSN: 2473-9537 ;DOI: 10.1182/bloodadvances.2019000449 ;PMID: 31714961Full text available |
18 |
Material Type: Article
|
![]() |
Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Relapsed, Refractory, and Transformed Indolent Non-Hodgkin's LymphomaJournal of clinical oncology, 2008-01, Vol.26 (2), p.211-217 [Peer Reviewed Journal]2008 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2007.11.5477 ;PMID: 18056679Full text available |
19 |
Material Type: Article
|
![]() |
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyriaBlood, 2007-03, Vol.109 (6), p.2618-2621 [Peer Reviewed Journal]2007 American Society of Hematology ;2007 by The American Society of Hematology 2007 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2006-06-022848 ;PMID: 17148589Full text available |
20 |
Material Type: Article
|
![]() |
Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic LeukaemiaFrontiers in pediatrics, 2022-01, Vol.9, p.805189-805189 [Peer Reviewed Journal]Copyright © 2022 Keogh, Dalle, Admiraal and Pulsipher. ;Copyright © 2022 Keogh, Dalle, Admiraal and Pulsipher. 2022 Keogh, Dalle, Admiraal and Pulsipher ;ISSN: 2296-2360 ;EISSN: 2296-2360 ;DOI: 10.3389/fped.2021.805189 ;PMID: 35071142Full text available |